Search
for

    Sort by

    Research 781–810 of 1000+

    1. A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits Journal of Drug Delivery and Therapeutics · 2019
    2. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    3. Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement The Journal of Urology · 2012
    4. 69-Year-Old Man With Nasal Congestion and Pre-Syncope Mayo Clinic Proceedings · 2021 · 1 citations
    5. Clinics in diagnostic imaging (221) Singapore Medical Journal · 2024
    6. THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH 2019
    7. Finasteride Drugs · 1993 · 86 citations
    8. The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist Respiratory Medicine · 2016 · 26 citations
    9. A practical guide to the standardization of hair loss photography for clinicians Clinical and Experimental Dermatology · 2024 · 4 citations
    10. An 85-Year-Old Man With Recurrent Fever and Multiple Splenic Infarcts Infectious diseases in clinical practice · 2018 · 1 citations
    11. PERANCANGAN PROGRAM APLIKASI PENGENALAN SUARA PADA WINDOWS MENGGUNAKAN FOURIER METHOD Acta urologica Belgica · 2009
    12. 69-Year-Old Man With Dysuria and Right Lower Abdominal Pain Mayo Clinic Proceedings · 2022
    13. Estrogen and androgen signaling in the pathogenesis of BPH Nature reviews. Urology · 2011 · 149 citations
    14. Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals European Journal of Drug Metabolism and Pharmacokinetics · 2008 · 11 citations
    15. Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin The Journal of Clinical Pharmacology · 1998 · 6 citations
    16. Analyzing finasteride data Neurourology and Urodynamics · 1995 · 6 citations
    17. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006 · 4 citations
    18. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis European urology focus · 2024
    19. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    20. Influence of Clinical and Sociodemographic Factors on the Management, Costs, and Outcomes of Acute Urinary Retention in the Acute Care Setting Urology Practice · 2022
    21. Dutasteride Drugs · 2008 · 45 citations
    22. Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations Analytical Chemistry Research · 2014 · 26 citations
    23. Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride Journal of Molecular Endocrinology · 2005 · 26 citations
    24. The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli Biomolecules · 2019 · 20 citations
    25. Spectrophotometric method for the estimation of finasteride in tablets Indian Journal of Pharmaceutical Sciences · 2002 · 4 citations
    26. A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride International Journal of Clinical Practice · 2013 · 3 citations
    27. Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis? Biomedicines · 2022 · 1 citations
    28. Reply to finasteride and dutasteride may reduce melanoma risk Cancer · 2015 · 1 citations
    29. Tamsulosin versus finasteride: effect on bother and urinary flow European Urology Supplements · 2002 · 1 citations
    30. Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement Postgraduate Medicine · 2026